Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia
Condition(s):Adrenal Gland NeoplasmsLast Updated:April 11, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Adrenal Gland NeoplasmsLast Updated:April 11, 2018Unknown status
Condition(s):Adrenal Gland NeoplasmsLast Updated:November 26, 2018Terminated
Condition(s):Adrenal Gland NeoplasmLast Updated:March 15, 2024Completed
Condition(s):Adrenal Tumor; Adrenalectomy; StatusLast Updated:March 13, 2024Recruiting
Condition(s):Complicated Adrenal Tumor DiseasesLast Updated:December 27, 2021Recruiting
Condition(s):Adrenal TumorsLast Updated:April 6, 2023Completed
Condition(s):Adrenal Gland NeoplasmsLast Updated:September 24, 2019Completed
Condition(s):Outcome Assessment; Adrenal NeoplasmLast Updated:June 22, 2023Completed
Condition(s):Neuroendocrine Tumors; Adrenal TumorLast Updated:March 8, 2024Not yet recruiting
Condition(s):Adrenal Tumor; Adrenal AdenomaLast Updated:October 10, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.